No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.

MLA

Beck-Friis, Josefine, et al. “No Difference in Biomarkers of Ischemic Heart Injury and Heart Failure in Patients with COVID-19 Who Received Treatment with Chloroquine Phosphate and Those Who Did Not.” PloS One, vol. 16, no. 8, Aug. 2021, p. e0256035. EBSCOhost, https://doi.org/10.1371/journal.pone.0256035.

APA

Beck-Friis, J., Leach, S., Omerovic, E., Zeijlon, R., Gisslen, M., & Yilmaz, A. (2021). No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not. PloS One, 16(8), e0256035. https://doi.org/10.1371/journal.pone.0256035

Chicago

Beck-Friis, Josefine, Susannah Leach, Elmir Omerovic, Rickard Zeijlon, Magnus Gisslen, and Aylin Yilmaz. 2021. “No Difference in Biomarkers of Ischemic Heart Injury and Heart Failure in Patients with COVID-19 Who Received Treatment with Chloroquine Phosphate and Those Who Did Not.” PloS One 16 (8): e0256035. doi:10.1371/journal.pone.0256035.